Alterations in arterial pressure in patients with Type 1 diabetes are associated with long-term poor metabolic control and a more atherogenic lipid profile.
OBJECTIVE
To determine the prevalence of alterations in blood pressure (BP) in patients with Type 1 diabetes who are normoalbuminuric and normotensive; and to evaluate the association with genetic, clinical and metabolic factors. MATERIAL/ METHODS: Normoalbuminuric, normotensive Type 1 diabetic patients (no.=85) had their ambulatory blood pressure monitoring (ABPM) performed over 24 h, together with measurement of HbA1c and lipid profile, polymorphisms of the ACE gene, non-midriatic retinography, and the "historical HbA1c" calculated (mean of all the determinations available on the patient).


RESULTS
Of the 85 patients, a mean of 18.8% had pathologic values of BP over the 24 h, 31.8% during active periods and 22.4% during rest periods; in 42% there was a non-dipper pattern in BP. The patients with alterations of BP had higher body mass index (BMI), higher levels of glycemia and of triglycerides, and decreased levels of HDL cholesterol. The "historical HbA1c" was significantly higher in the patients with the non-dipper pattern (8.6 ± 1.4% vs 7.9 ± 1.4%; p=0.046). Pulse pressure was directly associated with male gender (p=0.006) and with BMI (p=0.001). No differences were detected in the distribution of the polymorphisms of the ACE gene as a function of the BP alterations.


CONCLUSIONS
An elevated number normoalbuminuric, normotensive, Type 1 diabetic patients have alterations in BP detected with ABPM over 24 h, and these are associated with a greater BMI, poor long-term metabolic control and a more atherogenic lipid profile.
Vílchez-López
F J
FJ
Department of Endocrinology and Nutrition, Hospital Puerta del Mar, 11009 Cadiz, Spain. fjvil@hotmail.com
Carral-Sanlaureano
F
F
Coserria-Sánchez
C
C
Nieto
A
A
Jiménez
S
S
Aguilar-Diosdado
M
M
D000293:Adolescent; D000328:Adult; D001794:Blood Pressure / Q000502:physiology*; D018660:Blood Pressure Monitoring, Ambulatory; D015992:Body Mass Index; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000503:physiopathology*; D004734:Energy Metabolism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000503:physiopathology; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D055815:Young Adult
D008055:Lipids
Diabet Med. 2000 May;17(5):360-4
10872534
Diabetes Res Clin Pract. 2001 Aug;53(2):85-90
11403856
Blood Press Monit. 2002 Feb;7(1):3-17
12040236
J Hypertens. 2001 Aug;19(8):1421-8
11518850
Pediatr Nephrol. 2006 May;21(5):672-6
16568306
N Engl J Med. 2002 Sep 12;347(11):797-805
12226150
Diabetes Care. 1999 Jul;22(7):1151-7
10388981
Arch Intern Med. 2008 Sep 22;168(17):1867-73
18809813
Diabet Med. 1996 Jun;13(6):531-5
8799656
Ophthalmology. 2006 Dec;113(12):2231-6
16996597
Diabetes Metab Res Rev. 2009 Jul;25(5):442-51
19437445
Diabet Med. 2005 Aug;22(8):1054-9
16026372
Blood Press Monit. 2007 Apr;12(2):101-6
17353653
Diabet Med. 1994 May;11(4):357-61
8088107
J Hypertens. 2007 Jun;25(6):1105-87
17563527
J Hypertens. 1997 Dec;15(12 Pt 2):1579-92
9488209
Diabetes Care. 1994 Aug;17(8):824-7
7956625
Diabetes Care. 2008 Apr;31(4):720-5
18174497
Diabetes Care. 2003 Feb;26(2):355-9
12547862
Diabet Med. 2005 Jul;22(7):871-6
15975101
Am J Hum Genet. 1992 Jul;51(1):197-205
1319114
J Am Soc Nephrol. 2007 Jan;18(1):235-43
17151331
Diabetes Care. 2008 Jan;31 Suppl 1:S12-54
18165335
J Hum Hypertens. 2001 Apr;15(4):239-46
11319671
Blood Press Monit. 2005 Dec;10(6):307-10
16496445
Diabetes Care. 2005 Aug;28(8):2019-24
16043748